With proper instruction from specialty infusion therapy providers, self-administration in the home setting is a feasible option for many patients and can greatly improve quality of life.
Guidelines indicate that there are a number of treatment options for head and neck cancers.
Pharmacy accreditation programs can improve health care by providing standards by which to evaluate the quality of patient care services and by setting requirements for patient consultation, education, and documentation.
The $200 million fund created to compensate victims of the 2012 meningitis outbreak tied to tainted drugs is an extreme example of how expensive compounding errors can be.
Saxagliptin, in combination with metformin, provides a durable, well-tolerated, and cost-effective treatment option for patients with type 2 diabetes mellitus, from a US payer perspective.
More than 25% of US patients have not filled a prescription or have reduced their prescribed dose because of high costs.
High blood pressure reduces heart function and worsens comorbidities such as diabetes, kidney disease, and vascular disorders.
The placement of clinical pharmacists at the nexus of functional pharmacogenomics and in specialty pharmacy care makes good sense.
Pharmacists are essential in developing an individualized treatment regimen for each patient.
Vitamin D encompasses a group of fatsoluble secosterols that are found in certain foods and supplements and can also be produced when synthesis of vitamin D is triggered after the sun’s ultraviolet rays touch skin.
Incorporating community pharmacists into team-based care models is recommended as a strategy for improving health care access and quality while reducing health care costs.
A retrospective evaluation to assess whether medications for patients undergoing bariatric procedures are effectively optimized to ensure safe medication transitioning.
People have many reasons for wanting to become a pharmacist, ranging from personal encounters with pharmacists and witnessing experiences of friends and family members to stories they have read online about the profession.
For hospital pharmacies, the COVID-19 pandemic sparked an abrupt and intensive reevaluation of nearly every aspect of their operations.
2010 Patient Advocate of the Year Lisa Strucko makes patient care a top priority, expanding the clinical services of her pharmacy and counseling patients.
Differences in formulary coverage of antihypertensive medications for children between private and public insurance plans may impact physician prescribing practices and patient outcomes.
In outpatients with type 2 diabetes mellitus, persistent exenatide treatment lowered glycated hemoglobin and hyperglycemia in both genders. Waist circumference and body weight were more reduced in women.
Educating patients about lifestyle changes, strict medication adherence, and home blood pressure monitoring can help them to avert complications from this often silent condition.
The United States is in desperate need of an overhaul to the current health care system.
Diabetes is a disease that affects a person's life each day by having a negative effect on quality of life and creating a financial burden for patients and families.
Although naloxone delivery devices are proven to reduce opioid overdoses, challenges persist in increasing the use of these devices in the community setting.
Examination of changes in utilization, dose adequacy, and duration associated with market entry of the oral chelator deferasirox as a potential substitute for parenteral deferoxamine.
How can a multisite health system create a system pharmacy and therapeutics committee (P & T) that is meaningful for its acute care hospitals and infusion centers?
Medicare Part D plans can change their cost-sharing structure and formularies every year. As such, beneficiaries should annually reevaluate plan offerings to minimize their out-of-pocket costs.
The COVID-19 pandemic rapidly pushed traditional face-to-face instruction within schools of pharmacy into a fully remote learning environment.
This study seeks to determine the economic effects of warfarin discontinuation in patients with nonvalvular atrial fibrillation.